Most PAL [20], [22] and DLBCL-e [19] tumors are known to be immunohistochemically positive for LMP-1, and NKTLs are negative, or partially positive, for LMP-1 [23]–[25]. This evidence concerns the gene PDLIM7 and diffuse large B-cell lymphoma.